Study Summary
This trial will test whether sulindac can help reduce breast density in postmenopausal women who are at increased risk of breast cancer.
- Breast Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Sulindac
1 of 2
Placebo
1 of 2
Active Control
Non-Treatment Group
150 Total Participants · 2 Treatment Groups
Primary Treatment: Sulindac · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 35 - 70 · Female Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this trial the inaugural attempt at a study of its kind?
"Currently, 4 experiments surrounding Sulindac are being conducted across 623 cities in 2 different countries. In 2013, Cancer Prevention Pharmaceuticals, Inc. commenced a Phase 3 trial with 1340 participants; since then 18334 additional trials have been finalized." - Anonymous Online Contributor
Could you elucidate the potential risks of taking Sulindac?
"Taking into consideration the Phase 2 nature of this trial, our team at Power estimated Sulindac's safety to be a score of 2 due to limited data on its efficacy." - Anonymous Online Contributor
What is the maximum number of participants for this experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial continues its search for 150 participants at two different locations since it was first posted on November 20th 2020 and edited more recently on February 23rd 2022." - Anonymous Online Contributor
In what conditions is Sulindac typically prescribed?
"Generally, sulindac is utilized to manage acute subacromial bursitis. Additionally, the drug has been demonstrated to be effective for cases of [osteoarthritis](https://www.withpower.com/clinical-trials/osteoarthritis) (OA), acute supraspinatus tendinitis, and gouty arthritis." - Anonymous Online Contributor
Is enrollment for this research project still open?
"According to clinicaltrials.gov, this research project continues to search for additional participants since its first posting on November 20th 2020 and most recent update on February 23rd 2022." - Anonymous Online Contributor
Could you elucidate the past investigations that have utilized Sulindac?
"In 2013, Lake Norman Hematology Oncology Specialists-Mooresville first began examining sulindac. Nowadays, there are 18334 completed trials and 4 studies in the process of recruitment; many of these involve Stony Brook University's New York campus." - Anonymous Online Contributor